Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C404910 |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane |
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane affects the reaction [FSHB protein affects the expression of NR5A2 mRNA] | affects expression|affects reaction | 19414516
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of NR5A2 mRNA | decreases expression | 18648102
|
C508470 |
7-(2-(2,2-difluoroethoxy)-3,5-di-tert-butylbenzene)-3-methylocta-2,4,6-trienoic acid |
7-(2-(2,2-difluoroethoxy)-3,5-di-tert-butylbenzene)-3-methylocta-2,4,6-trienoic acid results in decreased expression of NR5A2 mRNA | decreases expression | 16357189
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of NR5A2 mRNA | affects expression | 17562736
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of NR5A2 protein | affects expression | 20106945
|
C103303 |
alitretinoin |
alitretinoin inhibits the reaction [NR5A2 protein promotes the reaction [[Forskolin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16357189
|
C103303 |
alitretinoin |
alitretinoin inhibits the reaction [NR5A2 protein results in increased expression of CYP19A1 mRNA] | decreases reaction|increases expression | 16357189
|
C103303 |
alitretinoin |
alitretinoin results in decreased expression of NR5A2 mRNA | decreases expression | 16357189
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NR5A2 mRNA | affects expression | 16483693
|
D001280 |
Atrazine |
Atrazine results in increased activity of NR5A2 protein | increases activity | 18461179
|
C477843 |
bicyclol |
bicyclol inhibits the reaction [Diethylnitrosamine results in increased expression of NR5A2 mRNA] | decreases reaction|increases expression | 17106253
|
D002635 |
Chenodeoxycholic Acid |
Chenodeoxycholic Acid results in decreased expression of NR5A2 mRNA | decreases expression | 15629111
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of NR5A2 mRNA | decreases expression | 20106945
|
D004052 |
Diethylnitrosamine |
bicyclol inhibits the reaction [Diethylnitrosamine results in increased expression of NR5A2 mRNA] | decreases reaction|increases expression | 17106253
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of NR5A2 mRNA | increases expression | 17106253
|
D004958 |
Estradiol |
Estradiol results in decreased expression of NR5A2 mRNA | decreases expression | 20106945
|
D004958 |
Estradiol |
Estradiol results in increased expression of NR5A2 mRNA | increases expression | 20607599
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of NR5A2 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NR5A2 mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of NR5A2 mRNA | decreases expression | 15834898
|
D005576 |
Forskolin |
alitretinoin inhibits the reaction [NR5A2 protein promotes the reaction [[Forskolin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16357189
|
D005576 |
Forskolin |
Forskolin results in increased expression of NR5A2 mRNA | increases expression | 16357189
|
D005576 |
Forskolin |
NR5A2 protein promotes the reaction [[Forskolin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA] | affects cotreatment|increases expression|increases reaction | 16357189
|
C516216 |
GSK 8470 |
GSK 8470 binds to and results in increased activity of NR5A2 protein | affects binding|increases activity | 17154495
|
C516216 |
GSK 8470 |
GSK 8470 promotes the reaction [NR5A2 protein results in increased expression of NR0B2 mRNA] | increases expression|increases reaction | 17154495
|
C017461 |
lead nitrate |
lead nitrate results in increased expression of NR5A2 mRNA | increases expression | 16049268
|
C095104 |
LG 100268 |
LG 100268 results in decreased expression of NR5A2 mRNA | decreases expression | 16357189
|
D010126 |
Ozone |
Ozone results in decreased expression of NR5A2 mRNA | decreases expression | 16183385
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of NR5A2 mRNA] | affects reaction|increases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of NR5A2 mRNA | increases expression | 19482888
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of NR5A2 mRNA | decreases expression | 18445702
|
D011374 |
Progesterone |
NR5A2 gene mutant form results in decreased abundance of Progesterone | decreases abundance | 17409375
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of NR5A2 mRNA | decreases expression | 20055451
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of NR5A2 mRNA | decreases expression | 17517823
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of NR5A2 mRNA | increases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NR5A2 mRNA | affects cotreatment|increases expression | 17942748
|
D013755 |
Tetradecanoylphorbol Acetate |
alitretinoin inhibits the reaction [NR5A2 protein promotes the reaction [[Forskolin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA]] | affects cotreatment|decreases reaction|increases expression|increases reaction | 16357189
|
D013755 |
Tetradecanoylphorbol Acetate |
NR5A2 protein promotes the reaction [[Forskolin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CYP19A1 mRNA] | affects cotreatment|increases expression|increases reaction | 16357189
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
7.72 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.72 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.39 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.77 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.96 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.07 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.07 | 14692618 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
6.34 | 3712494 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.34 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
23.44 | 17620307 19052882 17162532 16434500 18056438 19061943 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
23.44 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
23.44 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
23.44 | 16835633 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Atrazine |
4.05 | 11874814 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
2.40 | 15513908 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.80 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.67 | 10982225 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.29 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.56 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.52 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.59 | 17854713 16373670 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.43 | 18445737 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.85 | 11289319 1440618 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.25 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.25 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.62 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.65 | 15746008 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.17 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.09 | 15665606 15845082 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
2.89 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.89 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.89 | 18497071 16675129 12948864 17261762 17289903 19861407 17018787 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
LG 100268 |
2.89 | 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.89 | 16175315 17614352 15562024 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.89 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.54 | 15516495 17626835 16777450 19059883 18417511 14754758 18315731 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.57 | 16183385 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.29 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.66 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
11.02 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
11.02 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
11.02 | 21507988 12907637 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
11.02 | 3084413 16502159 19822196 16935385 19701751 16569478 18056438 19539802 20935162 20514400 18494052 17055752 17428255 20214788 11831363 17978847 19519916 16698587 20007298 20727157 20084675 16288022 18691550 17173139 19052882 16328049 20432363 17761372 18785209 19919837 17162532 18788625 18665156 16830150 18210153 19208518 20524982 16878318 10737359 18506893 19394651 16540662 20512989 10672840 16807293 19171122 18393292 17138121 19107877 16779866 20101231 18978308 19335982 19383236 18971187 19418558 21159647 3581430 16681979 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
11.02 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
11.02 | 20007298 17173139 1701930 6705139 20935162 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.60 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
2.91 | 18922899 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.27 | 16120746 18850075 18670907 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.48 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
15.04 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
15.04 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
15.04 | 2727394 7505956 17174075 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
15.04 | 18566989 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.08 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.84 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.84 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
18.17 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
18.17 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
18.17 | 16919318 16105132 17333356 11677210 17681005 15861022 17110522 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
18.17 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.03 | 15668235 8697196 12621046 15340226 16354765 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.91 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 15322242 10048152 20055451 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.64 | 11906362 14531868 12868966 11298694 8156756 8970840 18759878 2524372 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.35 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.33 | 3621924 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.08 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.08 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.27 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.32 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
11.49 | 18648102 18692083 18289764 6679447 6482804 9022650 8291058 11289319 9328219 16192314 1440618 9653073 7440962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
11.49 | 14550746 14986274 19164858 11421492 10774834 16109766 11529661 11461765 12392966 11287661 19420014 12958197 18713872 19370779 11743745 19416960 12153990 19923254 11739529 11834606 12540782 12705907 10663392 16177239 17906064 17562736 15619225 12594235 19739265 16781746 19085960 16485898 10915739 16393943 2444490 17522070 18071297 16081117 16227642 15968718 14725611 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
bicyclol |
11.49 | 15998439 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
11.49 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.49 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.93 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.63 | 11462148 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.84 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
10.57 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.57 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
10.57 | 8113982 7812673 8273558 11698051 9599246 16716910 15177302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.73 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
8.48 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
8.48 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.87 | 19148513 18566989 11473722 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.43 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.43 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.94 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.70 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.80 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.40 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.08 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.85 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.94 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.07 | 3581430 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.89 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
bicyclol |
23.01 | 16409862 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
23.01 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
23.01 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
23.01 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
23.01 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.29 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.85 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
7.92 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
7.92 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.50 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.05 | 8708960 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.88 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.42 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.24 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.43 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.25 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.18 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.35 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
13.39 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
13.39 | 19772884 19176532 16221962 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
13.39 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.86 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.58 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.87 | 8697196 16354765 16959395 15340226 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.57 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.03 | 20558911 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.77 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.73 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.73 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.64 | 16569931 16945680 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.23 | 15869954 |
MESH:D007247 |
Infertility, Female |
marker/mechanism |
|
| 17409375 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.30 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Atrazine |
6.53 | 12948887 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.53 | 17937319 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
11.26 | 18785209 |
MESH:D007249 |
Inflammation |
|
Progesterone |
11.26 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.26 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
11.26 | 7562506 8273558 15177302 7812673 11698051 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.83 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.83 | 16306350 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.85 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.18 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.27 | 15604871 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.46 | 16144296 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
9.41 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.41 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.41 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.55 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.55 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
11.55 | 15610895 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
6.33 | 18665156 19638242 18522880 18407596 20032147 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
6.33 | 21047994 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.09 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
bicyclol |
4.85 | 16603200 15730626 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
4.85 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.85 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.85 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
6.22 | 12969438 16610002 16611625 12587719 19460945 19784758 19014921 11587558 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.22 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
6.22 | 19363144 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.08 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
13.54 | 18177683 9163691 2125692 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
13.54 | 10737359 18977376 2422723 19499222 21047994 19812893 15885732 20137499 19073162 18648771 18754104 19255062 20492335 19294768 19427195 12112319 18644402 20452335 20405173 12771043 19256749 20101389 20501860 19638242 21167192 19996281 19551842 19642983 16942905 20583210 9163691 21278145 21071580 19690152 2862719 15175105 18978307 19254457 20434301 20118626 19090486 19833225 19850985 19426721 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
13.54 | 19812893 19482888 15975961 8742319 19073162 21047994 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
13.54 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
13.54 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
17.51 | 3712494 1399818 598648 6587162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
17.51 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
17.51 | 19009564 18093689 18544905 18164116 18282651 19126423 19519916 21159647 18308698 19004024 18079962 3124819 16267830 17174075 19539802 18253720 18775883 17942915 9362446 17854601 16842330 2563599 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
17.51 | 18308698 17172636 6150874 1399818 2563599 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
17.51 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.26 | 19066396 8266340 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.68 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
8.28 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
8.28 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
8.28 | 21163286 20970405 20512841 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
8.28 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.28 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
8.28 | 11807781 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
13.50 | 11807958 11408345 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
LG 100268 |
13.50 | 12374698 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
13.50 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
13.50 | 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.31 | 19453300 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.40 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Atrazine |
3.46 | 1916698 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.62 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.93 | 10496685 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.34 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.07 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.88 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.81 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.81 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.30 | 17484760 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.47 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
5.47 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
4.94 | 16946489 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.94 | 17405874 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.56 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.27 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.14 | 18481113 19348381 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
8.91 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.91 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
2.80 | 6679447 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.71 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
7.71 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.94 | 20387270 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.77 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.27 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.85 | 3988306 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.19 | 17016548 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.69 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
4.69 | 16525653 17393432 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.25 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
marker/mechanism |
|
| 20101243 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
8.34 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
8.34 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
8.34 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.53 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
8.83 | 7296757 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
8.83 | 8330346 12065085 18922899 18404319 |
MESH:D010300 |
Parkinson Disease |
|
Atrazine |
3.21 | 17218051 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.08 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.96 | 16369182 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.30 | 6228378 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.22 | 18007984 18381685 18929643 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.83 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.39 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
14.43 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
14.43 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
14.43 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.02 | 11222880 11118676 11399792 11896295 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.73 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.13 | 16740699 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.14 | 15861022 16919318 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.32 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.17 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.30 | 19058328 |
MESH:D012135 |
Respiratory Sounds |
|
Atrazine |
4.35 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.67 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.25 | 3692021 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.80 | 18045962 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
2.58 | 4039156 3137016 11442880 16876388 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.65 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.54 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
5.54 | 8985016 8330346 11807781 12065085 18404319 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.77 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.11 | 16503802 15862959 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.75 | 18456281 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.46 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.01 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.73 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.20 | 6582329 7505956 6587162 3712494 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
11.20 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
11.20 | 1399818 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.51 | 19048282 |
MESH:D014376 |
Tuberculosis |
|
Chenodeoxycholic Acid |
4.93 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.21 | 8074119 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.82 | 10982225 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.13 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.81 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.42 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.38 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.08 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.27 | 17120751 |